Dear Friends and Colleagues,
This is a unique year for the World Allergy Organization as we undertake two symposia with specific topics given local geographic context. The symposium in Rome on the topic of “Pediatric Allergy & Regulatory Aspects” was a great success and in just one week our second symposium, “Mite Allergy: From Basics to Clinical Applications” will begin in Cartagena, Colombia. >>Read More...
Inside the Issue
Dust Mites: From Basics to Clinical Applications
One Week Left!
6-9 September 2017
José Antonio Ortega Martell
Board Member, World Allergy Organization
Professor of Immunology, Faculty of Medicine
Autonomous University of Hidalgo State
Pachuca, Hildalgo, Mexico
Mexican College of Pediatricians Specialized in Allergy and Clinical Immunology (CoMPEDIA)
Mexican College of Allergy and Clinical Immunology (CMICA)
What inspired you to become involved in WAO?
I had the opportunity to participate in the organizing of the XVI International Congress of Allergology and Clinical Immunology (ICACI) in 1997 and afterwards in the XXII World Allergy Congress (WAC) both held in Cancún, México, first as local organizer and after as President of the Mexican College of Pediatricians Specialized in Allergy and Clinical Immunology (CoMPEDIA). These events gave me the opportunity to learn more about the World Allergy Organization and its educational outreach programs around the globe.
What would you like to share about the work of your national member societies?
In México, both of the national allergy and clinical immunology societies, CoMPEDIA and CMICA, work together in educational programs, symposia, national meetings and lectureships provided to any health care provider interested in the fields of allergy and clinical immunology, as well as to patients, families and the general population affected by these diseases.
What is one of your current interests in the field of allergy/clinical immunology?
I am especially interested in the pathophysiology of allergic diseases, as well as other clinical immunology ailments as primary immunodeficiencies and autoimmune disorders.
Larenas-Linneman D, Sala-Hernández J, Vásquez-García JC et al. Mexican Asthma Guidelines: GUIMA 2017. Rev Alerg Mex 2017; 64 Suppl 1:s11-s128. Abstract
Larenas-Linneman D, Sánchez-Borges M, Del Río-Navarro BE et al. Antihistamines for the treatment of urticaria in Mexico. Rev Alerg Mex 2015; 62(3):157-74. Abstract
The World Allergy Organization’s online education library includes programs for on-going learning for allergists and other medical practitioners interested in the care of the allergic patient. Here is a brief list to explore.
Case-based online learning modules:
- Bronchial Thermoplasty -- An Option for Difficult-to-Treat Severe Asthma
- Linking Upper & Lower Airways in Severe Asthma
- Management of Chronic Urticaria
- A Case of Urticaria
- Allergic Rhinitis with Asthma in Adults
- Management of Asthma with Co-morbid Allergic Rhinitis in Adults
- Allergic Rhinitis with Asthma in Children
- Management of Asthma with Co-morbid Allergic Rhinitis in Children
- Drug Allergy
- Food Allergy
- Allergic Rhinitis (Adult)
- Allergic Rhinitis (Children)
- Severe and Uncontrolled Asthma
Registration required, access free
Therapeutic interventions in severe asthma Read Article
Eosinophilic bioactivities in severe asthma Read Article
Small airways disease and severe asthma Read Article
Severe asthma and quality of life
Psychosocial, behavioral and lifestyle risk factors in pediatric asthma, a review
Upcoming Special Session on Asthma
7 September 2017
WAO Symposium & Congress of the Colombian Association of Allergy and Clinical Immunology
Presentation Titles and Speakers:
Genetics of Asthma
Kathleen Barnes, PhD, University of Colorado School of Medicine, and Johns Hopkins University
Asthma: Biomarkers and Phenotypes
Lanny J Rosenwasser, MD, University of Missouri at Kansas City, School of Medicine
Biologics in Severe Asthma: From Basics to Personalized Medicine
Carlos Serrano, MD, Fundación Valle del Lili, Cali, Colombia
WAO thanks Teva Pharmaceuticals, founding supporter, and Sanofi Genzyme and Regeneron Pharmaceuticals, for unrestricted educational grants.
Participate in WAC 2018, the AAAAI/WAO Joint Congress, in Orlando, Florida U.S.A. by submitting an abstract or case report. The deadline to submit an abstract, case report, or to apply for a travel grant is this Thursday, 31 August!
Editors' Choice Literature Review
Computational analysis of multimorbidity between asthma, eczema and rhinitis
Activities and resources
New Education Resources
What's New in Severe Asthma Research
Oral glucocorticoid–sparing effect of benralizumab in severe asthma
Small airways disease and severe asthma Read
Innate function of house dust mite allergens: robust enzymatic degradation of extracellular matrix at elevated pH Read
Allergic profiles of mothers and fathers in the Japan Environment and Children's Study (JECS): a nationwide birth cohort study Read
A partially hydrolyzed 100% whey formula and the risk of allergy: an updated meta-analysis Read
Is peanut causing food allergy in Cuba? Preliminary assessment of allergic sensitization and IgE specificity profile to peanut allergens in Cuban allergy patients Read
WAO International Scientific Conference (WISC) 2016, Abstracts Supplement Read
Randomised controlled trial of a baked egg intervention in young children allergic to raw egg but not baked egg Read
Psychoneuroimmunoendocrinology: clinical implications Read
World Allergy Organization Journal (WAO Journal) is the official journal of the World Allergy Organization (WAO), whose membership consists of 97 professional allergy, asthma and immunology from societies around the world. It is an open access, peer-reviewed global journal published by BioMed Central.
World Allergy Organization Journal publishes original research, clinical reviews, position papers, and epidemiological studies that contribute to current knowledge in patient care. The new Debates in Allergy Medicine series contributes the hottest current topics in allergy. The Journal aims to publish works with specific clinical relevance and practical measures that are critical for the practice of allergy anywhere in the world, to highlight the global impact of the allergy burden. The Journal provides a vehicle to highlight newer approaches for the evaluation of disease outcomes and concerning treatments and interventions.
World Allergy Organization Journal is interested in reviews and original research papers on:
Drug allergy in the era of biologics
Omic sciences in allergy
Ethics of publication in allergy
All articles published by World Allergy Organization Journal are made freely and permanently accessible online immediately upon publication, without subscription charges or registration barriers at https://waojournal.biomedcentral.com/articles.
Other benefits of publishing in World Allergy Organization Journal include:
- International exposure
- Rapid publication
- Blinded peer review process
- Open access
All articles published in World Allergy Organization Journal are included in: CAS, DOAJ, Embase, Emerging Sources Citation Index, PubMed, PubMed Central, SCImago, and Scopus.
The full text of all articles is deposited in digital archives around the world to guarantee long-term digital preservation.
Send your manuscript to the editors at email@example.com or submit online at https://www.editorialmanager.com/waoj/default.aspx.
For more information, visit the journal website http://www.waojournal.org.
Submission guidelines are available at: https://waojournal.biomedcentral.com/submission-guidelines.
Alessandro Fiocchi, MD and Erika Jensen-Jarolim, MD